Authors
Latest:
Robotic simple suprapubic prostatectomy for large prostatic adenomaThis video from Michael Lao, MD, Jacob A. Baber, MD, and Joseph R. Wagner, MD, depicts a minimally invasive robotic approach for a large symptomatic prostatic adenoma with bladder calculi.
Latest:
Robotic simple suprapubic prostatectomy for large prostatic adenomaThis video from Michael Lao, MD, Jacob A. Baber, MD, and Joseph R. Wagner, MD, depicts a minimally invasive robotic approach for a large symptomatic prostatic adenoma with bladder calculi.
Latest:
Robotic simple suprapubic prostatectomy for large prostatic adenomaThis video from Michael Lao, MD, Jacob A. Baber, MD, and Joseph R. Wagner, MD, depicts a minimally invasive robotic approach for a large symptomatic prostatic adenoma with bladder calculi.
Latest:
Patient selection, key steps for robotic simple prostatectomyIn this video, Stephen Summers, MD, and Ross Anderson, MD, introduce several techniques for treating large prostates with a robot-assisted simple prostatectomy.
Latest:
Patient selection, key steps for robotic simple prostatectomyIn this video, Stephen Summers, MD, and Ross Anderson, MD, introduce several techniques for treating large prostates with a robot-assisted simple prostatectomy.
Latest:
TKIs show modest activity in lenvatinib-exposed patients with advanced renal cell carcinomaPatients with advanced renal cell carcinoma treated with TKIs in the second or third line following lenvatinib treatment showed modest activity, highlighting the need for improved treatment options.
Latest:
Are reusable catheters safe? Study provides an answer"Patient perception is an important aspect of developing an effective treatment plan, and we should be able to arm patients with accurate data to help them make an informed decision," write Whitney Renee Smith, MD, and Gopal H. Badlani, MD.
Latest:
A patient’s dignity and daughter-and a race"Like most doctors, the majority of my day is spent handholding, counseling, relieving anxiety, and otherwise dealing with problems that aren’t necessarily medical," writes urologist Scott Donaldson, MD.
Latest:
PD-1 inhibitor shows some antitumor activity in prostate cancerWith additional follow-up of approximately 10 months, monotherapy with the PD-1 inhibitor pembrolizumab (Keytruda) continued to show antitumor activity in men with metastatic castration-resistant prostate cancer. However, monotherapy alone is likely not a sufficient treatment in this patient population, according to Emmanuel Antonarakis, MBBCh, professor of oncology at Johns Hopkins University in Baltimore, Maryland.
Latest:
Analysis suggests survival improved when cytoreductive nephrectomy added to immunotherapy in mRCCThe primary objective of the study was to assess the benefit of cytoreductive nephrectomy relative to immunotherapy regimens utilizing checkpoint inhibitors.
Latest:
Addressing resident burnout starts with program’s culture"I was overcome by the sinking notion that my career ambitions were regressing from thriving to surviving-a sentiment I know isn’t unique to my training. What may be unique, however, is how my program responded to increasingly evident signs of resident burnout," says James Anaissie, MD.
Latest:
How to code for cystoscopy with litholapaxy of more than 40 bladder calculi"If the documentation supported the use of modifier –22, it should be appended," write Jonathan Rubenstein, MD, and Mark Painter.
Latest:
Robotic ureteroscopy: The future of stone management?Advances in robotic URS will help target stones and reduce ionizing radiation.
Latest:
Robotic ureteroscopy: The future of stone management?Advances in robotic URS will help target stones and reduce ionizing radiation.
Latest:
Upper tract transitional cell carcinoma: Diagnostic and therapeutic considerationsDetermining grade of disease is important, as nephron-sparing approaches may be feasible.
Latest:
The case for transperineal prostate biopsy vs. the transrectal approachReduced infection rate may drive increased use of the transperineal approach.
Latest:
The case for transperineal prostate biopsy vs. the transrectal approachReduced infection rate may drive increased use of the transperineal approach.
Latest:
An end to the decline in prostate cancer mortality"The recently reported change in PCa death rates should prompt men to undergo genetic testing and have a discussion with their doctor regarding the benefits and potential harms of PSA-based screening based on their individualized risk of developing the disease," write Franklin Gaylis, MD, and A. Karim Kader, MD, PhD.
Latest:
An end to the decline in prostate cancer mortality"The recently reported change in PCa death rates should prompt men to undergo genetic testing and have a discussion with their doctor regarding the benefits and potential harms of PSA-based screening based on their individualized risk of developing the disease," write Franklin Gaylis, MD, and A. Karim Kader, MD, PhD.
Latest:
Bicycle riding: Good or bad for men’s health?Cycling has multiple benefits, and steps can be taken to prevent genitourinary injury.
Latest:
Bicycle riding: Good or bad for men’s health?Cycling has multiple benefits, and steps can be taken to prevent genitourinary injury.
Latest:
Updated AUA guidelines on BPH: What urologists need to knowThe updated guidelines focus on appropriate pre-procedure evaluation and novel surgical enhancements, according to Matthew D. Houlihan, DO, and Tobias S. Köhler, MD, MPH.
Latest:
Updated AUA guidelines on BPH: What urologists need to knowThe updated guidelines focus on appropriate pre-procedure evaluation and novel surgical enhancements, according to Matthew D. Houlihan, DO, and Tobias S. Köhler, MD, MPH.
Latest:
Telemedicine in urology: A crash course during the COVID-19 pandemic"Given that most urologic outpatient visits are non-urgent, almost all in-person visits should be eliminated out of appropriate concern for COVID-19," advise Drs. Gadzinski, Ellimoottil, Odisho, Watts, and Gore.
Latest:
Telemedicine in urology: A crash course during the COVID-19 pandemic"Given that most urologic outpatient visits are non-urgent, almost all in-person visits should be eliminated out of appropriate concern for COVID-19," advise Drs. Gadzinski, Ellimoottil, Odisho, Watts, and Gore.
Latest:
Telemedicine in urology: A crash course during the COVID-19 pandemic"Given that most urologic outpatient visits are non-urgent, almost all in-person visits should be eliminated out of appropriate concern for COVID-19," advise Drs. Gadzinski, Ellimoottil, Odisho, Watts, and Gore.
Latest:
Telemedicine in urology: A crash course during the COVID-19 pandemic"Given that most urologic outpatient visits are non-urgent, almost all in-person visits should be eliminated out of appropriate concern for COVID-19," advise Drs. Gadzinski, Ellimoottil, Odisho, Watts, and Gore.
Latest:
Expert Perspectives on the VIOLETTE Study and Future Directions in Prostate Cancer ResearchAmir H. Lebastchi, MD, provides perspectives on the VIOLETTE study and underscores the importance of future head-to-head trials to gain a deeper understanding of various treatment approaches.
Latest:
MRI/TRUS fusion-guided biopsy using UroNavPinto and colleagues provide an overview of MRI/TRUS fusion-guided transperineal biopsy utilizing the UroNav platform.
Latest:
MRI/TRUS fusion-guided biopsy using UroNavPinto and colleagues provide an overview of MRI/TRUS fusion-guided transperineal biopsy utilizing the UroNav platform.
